MoonLake Immunotherapeutics MLTX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's deferred tax assets and other non-current assets?
- MoonLake Immunotherapeutics (MLTX) reported deferred tax assets and other non-current assets of $1.34M in Q1 2026.
- How has MoonLake Immunotherapeutics's deferred tax assets and other non-current assets changed year-over-year?
- MoonLake Immunotherapeutics's deferred tax assets and other non-current assets decreased by 20.8% year-over-year, from $1.7M to $1.34M.